01 July 2026PayPoint Plc (the "Company") - Total Voting Rights and CapitalIn conformity with DTR 5.6.1 the Company hereby notifies the market of the following:As of 30 June 2026, the Company's share capital consisted of 59,862,665 ordinary shares of £0.003611. Each ordinary share carries the right…
ICG plc (the “Company”)1 July 2026Admission to TradingIn accordance with PRM 1.6.4R of the FCA’s Prospectus Rules:Admission to Trading on a Regulated Market sourcebook, the Company announces that shares have been admitted to trading as follows:Enquiries:Chris HuntHead of Corporate Development and S…
DEKUPLE Group continues its European growth with a majority stake acquisition in subko&co in PolandParis, July 1st, 2026 (8:00 a.m.) – DEKUPLE Group, a European leader in communication and data marketing, announces the acquisition of a majority stake in subko&co, a Polish agency combining performan…
Volta Finance Limited (VTA/VTAS)Dividend DeclarationNOT FOR RELEASE, DISTRIBUTION OR PUBLICATION,IN WHOLE OR IN PART, IN OR INTO THE UNITED STATESGuernsey, 1 July 2026Volta Finance Limited ("the Company") hereby announces that it has declared a quarterly interim dividend of €0.135 per share payable…
Schiphol, July 1, 2026 - Aegon today begins a EUR 200 million share buyback that was announced during the Capital Markets Day on December 10, 2025. This share buyback is expected to be completed by December 23, 2026, barring unforeseen circumstances. Aegon intends to cancel the shares it repurchase…
EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX’s TRANSPLANT LAB PRODUCT DIVISIONParis, July 1st, 2026 ,8 AM CETEurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in-vitro diagnostics for transplantation, oncology and infectious diseases, today announces th…
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSNeuberger Private Equity Partners Limited Announces Total Voting RightsSt Peter Port, Guernsey 1 July 2026…
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONSNeuberger Private Equity Partners Announces Transaction in Own SharesSt Peter Port, Guernsey 1 July 2026Ne…
FORESIGHT VCT PLCLEI:213800GNTY699WHACF46TOTAL VOTING RIGHTS1 JULY 2026In conformity with DTR 5.6.1R, the Company announces that, as at 30 June 2026, the Company's issued share capital consisted of 351,918,283 Ordinary Shares in issue.There are no shares held in Treasury.The total number of voting…
Octopus Apollo VCT plcTotal Voting Rights and CapitalOctopus Apollo VCT plc (‘the Company’) announces that as at 30 June 2026 its issued share capital consists of 1,178,852,684 Ordinary shares of 0.1p each. The Company holds no shares in treasury and the total voting rights in the Company are…
DIVERSIFIED ENERGY COMPANY("Diversified", or the "Company")DIVERSIFIED ENERGY COMPANY NYSE:DEC; LSE:DEC announces that, in accordance with the terms of its share buyback program announced on March 20, 2025, the Company has purchased 328,781 shares of common stock, par value $0.01 per share of the C…
Octopus Titan VCT plcTotal Voting Rights and CapitalOctopus Titan VCT plc (‘the Company’) announces that as at 30 June 2026 its issued share capital consists of 1,648,217,720 Ordinary shares of 0.1p each. The Company holds no shares in treasury and the total voting rights in the Company are 1,648,2…
ICG Enterprise Trust plc (the “Company”)1 July 2026Total Voting RightsIn accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, the Company announces as follows.At the close of business on 30 June 2026, the Company had 63,554,192 Ordinary shares in issue, of which 2,713,878 wer…
More information is available on Aedifica’s website via the link below and can be accessed subject to the usual restrictions.
Abivax announces temporary trading halt of its ordinary shares on Euronext ParisPARIS, France, July 1, 2026 – 07:30 a.m. CEST – Abivax SA (Euronext Paris:FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body…
Availability of the aide-mémoire for Q2 2026 resultsParis, France – July 1, 2026. Sanofi announced today the availability of the aide-mémoire for Q2 2026 results on the "Investors" page of sanofi.com:Second quarter 2026 resultsPrepared each quarter, this document is intended to support financial mo…
EfTEN United Property Fund has entered into a sale agreement with UAB M7 investicijos (Lithuanian company registry code 307671275) for the sale of its subsidiary EfTEN M7 UAB, which owns the office building at Menulio 7 in Vilnius. The transaction is structured as a share deal selling the 100% subs…
State authority initiates public commenting phase following positive human health assessment, marking key step toward potential state registrationGhent, BELGIUM, July 01, 2026 (GLOBE NEWSWIRE) -- Press ReleaseBiotalys (Brussels:BTLS">Euronext Brussels:BTLS), an Agricultural Technology (AgTech) com…
Ad hoc announcement pursuant to Art. 53 LRIdorsia appoints Roland Wandeler as CEO – effective October 1, 2026 – an experienced biopharmaceutical executive combining scientific expertise with business acumen to translate innovation into performance and lead Idorsia’s next phase of growthAllschwil, S…
